<DOC>
	<DOCNO>NCT02172235</DOCNO>
	<brief_summary>The objective investigate effect different dos BI 10773 bioavailability pioglitazone multiple oral dos drug</brief_summary>
	<brief_title>Relative Bioavailability Pioglitazone After Co-administration With Different Doses BI 10773 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Empagliflozin</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>1 . Healthy male subject accord follow criterion : medical history , physical examination , vital sign ( ( blood pressure ( BP ) , pulse rate ( PR ) , 12lead electrocardiogram ( ECG ) ) , clinical laboratory test 2 . Age 18 55 year ( incl . ) 3 . BMI 18.5 29.9 kg/m2 ( incl . ) 4 . Signed date write informed consent prior admission study accordance Good Clinical Practise ( GCP ) local legislation 1 . Any finding medical examination include blood pressure ( BP ) , pulse rate ( PR ) electrocardiogram ( ECG ) deviate normal clinical relevance 2 . Any evidence clinically relevant concomitant disease 3 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 4 . Surgery gastrointestinal tract ( except appendectomy ) 5 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 6 . History relevant orthostatic hypotension , faint spell blackout . 7 . Chronic relevant acute infection 8 . History relevant allergy/hypersensitivity ( include allergy drug excipients ) 9 . Intake drug long halflife ( 24 hour ) within least one month le 10 halflives respective drug prior administration trial 10 . Participation another trial investigational drug within two month prior administration trial 11 . Smoker ( 10 cigarette 3 cigar 3 pipes/day ) 12 . Inability refrain smoke trial day 13 . Alcohol abuse ( 30 g/day ) 14 . Drug abuse 15 . Blood donation ( 100 mL within four week prior administration trial ) 16 . Excessive physical activity ( within one week prior administration trial ) 17 . Alanine aminotransferase ( ALT ) outside normal range laboratory value outside reference range clinical relevance 18 . Inability comply dietary regimen trial site 19 . Galactose lactose intolerance , galactose glucose malabsorption</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>